English
Home > Products > 2-Formylfuran-5-boronic

China 2-Formylfuran-5-boronic Factory

We believe that prolonged expression partnership is usually a result of high quality, benefit added assistance, rich encounter and personal contact for 2-Formylfuran-5-boronic,CAS NO 27329-70-0,27329-70-0,Lapatinib intermediate,Lapatinib advance intermediate, Welcome around the world consumers to speak to us for organization and long-term cooperation. We'll be your reputable partner and supplier of auto areas and accessories in China.
2-Formylfuran-5-boronic, You can always find the products and solutions you need to have in our company! Welcome to inquire us about our product and anything we know and we can help in auto spare parts. We're looking forward to work with you for a win-win situation.

Related Products

Hot Products

  • (S)-4,5,6,7-Tetrahydro-2,6-benzothiazolediamine

    (S)-4,5,6,7-Tetrahydro-2,6-benzothiazolediamine

    Product Name:(S)-4,5,6,7-Tetrahydro-2,6-benzothiazolediamine
    Molecular Formula:C7H11N3S
    Molecular Weight:169.25
    CAS Registry Number:106092-09-5
  • MB-07133

    MB-07133

    Product Name:MB-07133
    Molecular Formula:C26H28N4O3
    Molecular Weight;444.53
    CAS Registry Number;1190389-15-1
  • Vinpocetine

    Vinpocetine

    Product Name:Vinpocetine
    Molecular Formula:C22H26N2O2
    Molecular Weight;350.46
    CAS Registry Number;42971-09-5
  • 2-chloro-5-(2-fluorophenyl)-1H-pyrrole-3-carbonitrile

    2-chloro-5-(2-fluorophenyl)-1H-pyrrole-3-carbonitrile

    Product Name:2-chloro-5-(2-fluorophenyl)-1H-pyrrole-3-carbonitrile
    Molecular Formula:C11H6ClFN2
    Molecular Weight:220.63
    CAS Registry Number:1240948-72-4
  • 5-Bromo-2-Chlorobenzoic Acid

    5-Bromo-2-Chlorobenzoic Acid

    Product Name:5-Bromo-2-Chlorobenzoic Acid
    CAS NO:21739-92-4
    Molecular Formula:C7H4BrClO2
    Formula Weight:235.46
    Usage:Dapagliflozin Intermediates​
  • 2-Fluoro-5-bromobenzotrifluoride

    2-Fluoro-5-bromobenzotrifluoride

    Product Name:2-Fluoro-5-bromobenzotrifluoride
    Molecular Formula:C7H3BrF4
    Molecular Weight:243
    CAS Registry Number:393-37-3
  • Related Blog
  • Reviews

  • How to find the best China API manufacturer?

    Active pharmaceutical ingredients or APIs can be defined as the chemicals used to manufacture pharmaceutical drugs. The active ingredient (AI) is the substance or substances that are biologically active within the drug and is the specific component responsible for the desired effect it has on the individual taking it.

  • Pharmaceutical Intermediates Manufacturers - Something You Need to Know About Pharma Intermediates Industry

    Pharmaceutical intermediates are actually chemical raw materials or chemical products that need to be used in the synthesis of drugs. Such chemical products...

  • What is the difference between API and FDF in pharma？

    In the pharmaceutical industry, you might hear the terms “FDF” and “API” frequently used in reference to products. We surely understand this type of jargon, but we certainly can see how the general public would feel overwhelmed looking at those kinds of terminology abbreviations. This article is for explaining the difference between API and FDF. For reference, they mean, respectively, “finished dosage form” and “active pharmaceutical ingredient.”

  • CAS No. 144689-24-7 Olmesartan Introduction

    Olmesartan is an angiotensin II receptor blocker, widely used for the treatment of hypertension. The Renin-Angiotensin-Aldosterone System (RAAS) plays an importent role in the development and progression of many diseases such as hypertension...

  • What is an Active Pharmaceutical Ingredient (API in Pharma)?

    Sandoo Pharmaceutical is a professional active pharmaceutical intermediate manufacturer, producing high quality APIs. Sandoo Pharmaceutical provides a wide range of active pharmaceutical intermediates.

  • FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

    On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

Related Search

2-Formylfuran-5-boronic acid

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept